Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TEDA-9 by S.Biomedics for Parkinson's Disease: Likelihood of Approval
TEDA-9 is under clinical development by S.Biomedics and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase II...
Clenbuterol hydrochloride by CuraSen Therapeutics for Parkinson's Disease: Likelihood of Approval
Clenbuterol hydrochloride is under clinical development by CuraSen Therapeutics and currently in Phase II for Parkinson's Disease. According to GlobalData,...
UCB-7853 by UCB for Parkinson's Disease: Likelihood of Approval
UCB-7853 is under clinical development by UCB and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...